ATE174516T1 - Verfahren zur fixierung von biologischen geweben - Google Patents

Verfahren zur fixierung von biologischen geweben

Info

Publication number
ATE174516T1
ATE174516T1 AT92307101T AT92307101T ATE174516T1 AT E174516 T1 ATE174516 T1 AT E174516T1 AT 92307101 T AT92307101 T AT 92307101T AT 92307101 T AT92307101 T AT 92307101T AT E174516 T1 ATE174516 T1 AT E174516T1
Authority
AT
Austria
Prior art keywords
tissue
solution
aprotic solvent
polyurethane
diisocyanate
Prior art date
Application number
AT92307101T
Other languages
English (en)
Inventor
Eugene Khor
Swee Hin Teoh
Kerm Sin Chian
Weng Keong Loke
Singapore
Original Assignee
Univ Singapore
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Singapore filed Critical Univ Singapore
Application granted granted Critical
Publication of ATE174516T1 publication Critical patent/ATE174516T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • A01N1/12—Chemical aspects of preservation
    • A01N1/122—Preservation or perfusion media
    • A01N1/125—Freeze protecting agents, e.g. cryoprotectants or osmolarity regulators
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/18—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
    • A61L27/3687—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by the use of chemical agents in the treatment, e.g. specific enzymes, detergents, capping agents, crosslinkers, anticalcification agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/42—Anti-thrombotic agents, anticoagulants, anti-platelet agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/40—Preparation and treatment of biological tissue for implantation, e.g. decellularisation, cross-linking

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Veterinary Medicine (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Environmental Sciences (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Dentistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Botany (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Materials For Medical Uses (AREA)
  • Polyurethanes Or Polyureas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT92307101T 1992-07-15 1992-08-04 Verfahren zur fixierung von biologischen geweben ATE174516T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929215002A GB9215002D0 (en) 1992-07-15 1992-07-15 Method of fixing biological tissue

Publications (1)

Publication Number Publication Date
ATE174516T1 true ATE174516T1 (de) 1999-01-15

Family

ID=10718725

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92307101T ATE174516T1 (de) 1992-07-15 1992-08-04 Verfahren zur fixierung von biologischen geweben

Country Status (5)

Country Link
EP (1) EP0578885B1 (de)
AT (1) ATE174516T1 (de)
DE (1) DE69227900T2 (de)
GB (1) GB9215002D0 (de)
SG (1) SG78235A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010053839A1 (en) * 2000-06-19 2001-12-20 Koken Co. Ltd. Biomedical material and process for making same
US20050220835A1 (en) * 2004-03-30 2005-10-06 Jayaraman Ramesh B Agent eluting bioimplantable devices and polymer systems for their preparation
DE102007025277A1 (de) 2007-05-31 2008-12-04 Qiagen Gmbh Verfahren zur Stabilisierung einer biologischen Probe
US11021733B2 (en) 2011-09-26 2021-06-01 Qiagen Gmbh Stabilization and isolation of extracellular nucleic acids
ES2574956T3 (es) 2011-09-26 2016-06-23 Preanalytix Gmbh Estabilización y aislamiento de ácidos nucleicos extracelulares
ES2971646T3 (es) * 2011-09-26 2024-06-06 Preanalytix Gmbh Estabilización y aislamiento de ácidos nucleicos extracelulares
CA2884915C (en) 2012-09-25 2022-05-17 Qiagen Gmbh Stabilisation of biological samples
EP2976424B1 (de) 2013-03-18 2018-10-03 Qiagen GmbH Stabilisierung von biologischen proben
WO2014146782A1 (en) * 2013-03-18 2014-09-25 Qiagen Gmbh Stabilization and isolation of extracellular nucleic acids
CN114457068B (zh) 2015-11-20 2025-03-14 普瑞阿那利提克斯有限公司 用于稳定细胞外核酸的已灭菌组合物的制备方法
RU2752505C1 (ru) * 2020-12-11 2021-07-28 Общество с ограниченной ответственностью "Инжиниринговый химико-технологический центр" Бесформальдегидный фиксатор биоматериала для гистологических и иммуногистохимических исследований

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8413319D0 (en) * 1984-05-24 1984-06-27 Oliver Roy Frederick Biological material
EP0245383A4 (de) * 1985-11-13 1988-06-08 Domedica Pty Ltd Behandlung von kollagengewebe.
JPH0712375B2 (ja) * 1986-11-17 1995-02-15 株式会社高研 移植組成物及びその製造方法
FR2645870B1 (fr) * 1989-04-12 1993-01-22 Bioetica Sa Procede de reticulation du collagene par le diphenylphosphorylazide, collagene reticule ainsi obtenu et biomateriaux a base de collagene ainsi reticules

Also Published As

Publication number Publication date
GB9215002D0 (en) 1992-08-26
EP0578885A3 (en) 1994-07-13
EP0578885A2 (de) 1994-01-19
DE69227900D1 (de) 1999-01-28
DE69227900T2 (de) 1999-05-12
SG78235A1 (en) 2001-02-20
EP0578885B1 (de) 1998-12-16

Similar Documents

Publication Publication Date Title
ATE174516T1 (de) Verfahren zur fixierung von biologischen geweben
ATE131686T1 (de) Verfahren zur revitalisierung von zellen vor dem einfrieren
DE59010917D1 (de) Verfahren zur Herstellung von Uretdiongruppen aufweisenden Polyisocyanaten
DE59811531D1 (de) Verfahren zur Herstellung von Polyisocyanaten
DK0665854T3 (da) Katalysatorer til hærdning af blokerede isocyanater og isothiocyanater ved lav temperatur
DE59304248D1 (de) Mehrstufenprozess zur Herstellung von thermoplastisch verarbeitbaren Polyurethan-Elastomeren
DE59502140D1 (de) Verfahren zur Herstellung von thermoplastischen Polyurethanelastomeren (TPU)
DE69126646D1 (de) Biologisches Verfahren zur Herstellung von optisch-aktiver Milchsäure
ATE252825T1 (de) Verlängerte lagerung roter blutzellen
DE59006000D1 (de) Verfahren zur Herstellung von flexiblen Polyesterpolyurethanschäumen.
DE59904616D1 (de) Verwendung von Metallsalzen der Ricinolsäure bei der Herstellung von Polyurethanschäumen
DE3861558D1 (de) Verfahren zur herstellung von 1-chlor-1,1-difluoraethan.
ATE145895T1 (de) Stabile nach phosgenfreien verfahren erhältliche polyisocyanatzusammensetzungen und ein verfahren zu ihrer herstellung
DE3887197D1 (de) Verfahren zur Herstellung von Glucosedehydrogenase aus Bacillus megaterium.
ATE295381T1 (de) Verfahren zur herstellung von polyurethan- weichschaumstoffen
DE59308152D1 (de) Mehrstufenprozess zur Herstellung von thermoplastisch verarbeitbaren Polyurethan-Elastomeren
DE59404760D1 (de) Verfahren zur Herstellung von Polyurethan Harschaumstoffen
DE68926417D1 (de) Verfahren zur herstellung von optisch aktiven 2-hydroxysäureabkömmlingen
DE59106876D1 (de) Verfahren zur enzymatischen Herstellung optisch aktiver Cyanhydrine.
ATE72269T1 (de) Verfahren zur herstellung von fluorierten acrylsaeuren und ihren derivaten.
DE3882940D1 (de) Verfahren zur herstellung von biuretpolyisocyanaten, die nach diesem verfahren erhaltenen verbindungen und ihre verwendung.
ATE77825T1 (de) Verfahren zur herstellung von polyurethanharnstoff-elastomeren.
DE3853269D1 (de) Temperaturkontrolliertes Verfahren zur Herstellung von als Adjuvans für Detergentien verwendbaren 2'2'-Oxodisuccinten.
ATE167674T1 (de) Verfahren zur herstellung von l-ascorbinsäure
DE68912504D1 (de) Verfahren zur Herstellung von optisch aktiver beta-Halomilchsäure oder Glycidsäure.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties